New CAR-T therapy aims to tackle Hard-to-Treat multiple myeloma
NCT ID NCT06615479
First seen Jun 24, 2026 · Last updated Sep 16, 2026 · Updated 7 times
Summary
This phase 3 trial is testing a new CAR-T cell therapy called arlo-cel against standard treatments for adults with multiple myeloma that has come back or stopped responding to previous therapies. About 440 participants will receive either arlo-cel or a standard regimen. The study will compare how long the cancer stays under control and how well patients respond.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- arlocabtagene autoleucel (arlo-cel), a CAR-T cell therapy targeting GPRC5D
- What this could lead to
- If successful, this could offer a more effective treatment option for people with multiple myeloma that has returned or not responded to prior therapies.
- What could go wrong
- This is an early-phase 3 trial, so results are not yet confirmed. CAR-T therapies can cause serious side effects like cytokine release syndrome and neurological problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 440 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2025
- Expected to finish
-
Jun 2032
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria * Participants must have relapsed or refractory multiple myeloma (RRMM). * Participants must have received at least 1 but no greater than 3 prior multiple myeloma (MM) regimens which may include a proteasome inhibitor (PI), an immunomodulatory drug (IMiD), and an anti-CD38 monoclonal antibody and have prior exposure to lenalidomide. * Participants must have a documented diagnosis of MM as per International Myeloma Working Group Criteria. * Participants must have measurable disease during screening. * Participants must have adequate organ function. * Participants must have an Eastern Cooperative Oncology group performance status 0 or 1. Exclusion Criteria * Participants must not have known active or history of central nervous system (CNS) involvement of Multiple Myeloma (MM). * Participants must not have solitary plasmacytomas or non-secretory myeloma without other evidence of measurable disease. * Participants must not need urgent treatment due to rapidly progressing MM. * Other protocol-defined Inclusion/Exclusion criteria apply.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Relapsed or refractory multiple myeloma (RRMM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
133 sites in 31 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
A. C. Camargo Cancer Center
RECRUITINGSão Paulo, São Paulo, 01509-010, Brazil
-
AHN West Penn Hospital
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
-
Aarhus Universitetshospital, Skejby
RECRUITINGAarhus, Central Jutland, 8200, Denmark
-
Addenbrooke's Hospital
RECRUITINGCambridge, Cambridgeshire, CB2 2QQ, United Kingdom
-
Amsterdam UMC, locatie VUmc
RECRUITINGAmsterdam, North Holland, 1081 HV, Netherlands
-
Antwerp University Hospital
RECRUITINGEdegem, Antwerpen, 2650, Belgium
-
Arthur J.E. Child Comprehensive Cancer Centre
RECRUITINGCalgary, Alberta, T2N 5G2, Canada
-
Asan Medical Center
RECRUITINGSeoul, Seoul-teukbyeolsi [Seoul], 05505, South Korea
-
Attikon General University Hospital
RECRUITINGChaïdári, Attikí, 12462, Greece
-
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino
RECRUITINGTurin, Piedmont, 10126, Italy
-
Baptist MD Anderson Cancer Center
RECRUITINGJacksonville, Florida, 32207, United States
-
Boston Medical Center
RECRUITINGBoston, Massachusetts, 02118, United States
-
CHUS - Hospital Clinico Universitario
RECRUITINGSantiago de Compostela, A Coruña [La Coruña], 15706, Spain
-
CIUSSS de l'Est-de-l'Île-de-Montréal
RECRUITINGMontreal, Quebec, H1T 2M4, Canada
-
Cantonal Hospital St.Gallen
RECRUITINGSankt Gallen, Canton of St. Gallen, 9007, Switzerland
-
Centre Hospitalier Lyon Sud
RECRUITINGPierre-Bénite, Rhône, 69310, France
-
Centre Hospitalier Universitaire de Nantes - L' Hopital l'hôtel-Dieu
RECRUITINGNantes, Pays de la Loire Region, 44000, France
-
Centrum Onkologii Ziemi Lubelskiej
RECRUITINGLublin, Lublin Voivodeship, 20-090, Poland
-
Charité Campus Virchow-Klinikum
RECRUITINGBerlin, 13353, Germany
-
China Medical University Hospital
RECRUITINGTaichung, 404332, Taiwan
-
Churchill Hospital
RECRUITINGOxford, Oxfordshire, OX3 7LE, United Kingdom
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
-
Clinica Universidad de Navarra
RECRUITINGPamplona, Navarre, 31008, Spain
-
Cliniques universitaires Saint-Luc
RECRUITINGBrussels, Bruxelles-Capitale, Région de, 1200, Belgium
-
Debreceni Egyetem Klinikai Kozpont
RECRUITINGDebrecen, Hajdú-Bihar, 4032, Hungary
-
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi
RECRUITINGAnkara, 06200, Turkey (Türkiye)
-
Evangelismos General Hospital of Athens
RECRUITINGAthens, Attikí, 106 76, Greece
-
Fakultni nemocnice Hradec Kralove
RECRUITINGHradec Králové, Hradec Králové, 500 05, Czechia
-
Fakultni nemocnice Ostrava
RECRUITINGOstrava, Moravian-Silesian Region, 708 52, Czechia
-
Fakultní nemocnice Brno Bohunice
RECRUITINGBrno, Brno-město, 625 00, Czechia
-
Fiona Stanley Hospital
RECRUITINGMurdoch, Western Australia, 6150, Australia
-
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITINGMilan, Lombardy, 20133, Italy
-
Freeman Hospital
RECRUITINGNewcastle upon Tyne, NE7 7DN, United Kingdom
-
Fundeni Clinical Institute
RECRUITINGBucharest, Bucharest, 022328, Romania
-
Georgetown University Medical Center
RECRUITINGWashington D.C., District of Columbia, 20007, United States
-
Hadassah Medical Center
RECRUITINGJerusalem, Jerusalem, 9112001, Israel
-
Hamilton Health Sciences-Juravinski Cancer Centre
RECRUITINGHamilton, Ontario, L8V5C2, Canada
-
Hanusch-Krankenhaus
RECRUITINGVienna, 1140, Austria
-
Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus)
RECRUITINGHelsinki, Uusimaa, 00029, Finland
-
Henri Mondor Hospital
RECRUITINGCréteil, Val-de-Marne, 94010, France
-
Hopital Claude Huriez - CHU de Lille
RECRUITINGLille, Nord, 59000, France
-
Hospital Aleman
RECRUITINGBuenos Aires, Buenos Aires F.D., C1118AAT, Argentina
-
Hospital Italiano de Buenos Aires
RECRUITINGABB, Buenos Aires F.D., C1199ABB, Argentina
-
Hospital Universitari Son Espases
RECRUITINGPalma, Balears [Baleares], 07120, Spain
-
Hospital Universitario Virgen Nieves
RECRUITINGGranada, 18012, Spain
-
Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca
RECRUITINGSalamanca, 37007, Spain
-
Huntsman Cancer Institute
RECRUITINGSalt Lake City, Utah, 84112, United States
-
Hyogo Medical University Hospital
RECRUITINGNishinomiya, Hyōgo, 663-8501, Japan
-
Hôpital Saint-Louis
RECRUITINGParis, 75010, France
-
IRCCS AOM Azienda Ospedaliera Metropolitana
RECRUITINGGenova, 16132, Italy
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola
RECRUITINGBologna, 40138, Italy
-
Inselspital Bern
RECRUITINGBern, Canton of Bern, 3010, Switzerland
-
Institut Catalan d Oncologia (ICO) - Badalona
RECRUITINGBadalona, Barcelona [Barcelona], 08916, Spain
-
Instituto D'Or de Pesquisa e Ensino (IDOR)
RECRUITINGSão Paulo, 01401-002, Brazil
-
Instituto Português de Oncologia do Porto Francisco Gentil, EPE
RECRUITINGPorto, 4200-072, Portugal
-
Institutul Regional de Oncologie
RECRUITINGIași, 700483, Romania
-
Istituto Clinico Humanitas
RECRUITINGRozzano, Milano, 20089, Italy
-
Japanese Red Cross Medical Center
RECRUITINGShibuya-ku, Tokyo, 150-8935, Japan
-
Kanazawa University Hospital
RECRUITINGKanazawa, Ishikawa-ken, 920-8641, Japan
-
Karolinska Universitetssjukhuset Huddinge
RECRUITINGHuddinge, 141 86, Sweden
-
Klinikum Chemnitz - Flemmingstraße
RECRUITINGChemnitz, Saxony, 09116, Germany
-
Klinikum Nuernberg Nord
RECRUITINGNuremberg, 90419, Germany
-
Kumamoto University Hospital
RECRUITINGKumamoto, 860-8556, Japan
-
Kyushu University Hospital
RECRUITINGFukuoka, 812-8582, Japan
-
Levine Cancer Institute
RECRUITINGCharlotte, North Carolina, 28204, United States
-
Levine Cancer Institute
RECRUITINGCharlotte, North Carolina, 28204, United States
-
Liverpool Hospital
RECRUITINGLiverpool, New South Wales, 2170, Australia
-
Local Institution - 0012
NOT_YET_RECRUITINGNova Lima, Minas Gerais, 34000-000, Brazil
-
Local Institution - 0084
NOT_YET_RECRUITINGKatowice, 40-519, Poland
-
Local Institution - 0097
ACTIVE_NOT_RECRUITINGPhiladelphia, Pennsylvania, 19111, United States
-
Local Institution - 0125
WITHDRAWNBudapest, 1097, Hungary
-
Local Institution - 0178
NOT_YET_RECRUITINGRiyadh, 12713, Saudi Arabia
-
Local Institution - 0181
WITHDRAWNSingapore, Central Singapore, 169608, Singapore
-
Local Institution - 0214
WITHDRAWNABB, Buenos Aires F.D., C1199ABB, Argentina
-
Local Institution - 0219
WITHDRAWNMinneapolis, Minnesota, 55455, United States
-
Local Institution - 0221
WITHDRAWNStony Brook, New York, 11794, United States
-
Local Institution - 0227
WITHDRAWNCharleston, South Carolina, 29425, United States
-
Local Institution - 0228
WITHDRAWNOrlando, Florida, 32804, United States
-
Louisiana State University Health Sciences Shreveport
RECRUITINGShreveport, Louisiana, 71103, United States
-
Maastricht UMC+
RECRUITINGMaastricht, Limburg, 6229 HX, Netherlands
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Medizinische Hochschule Hannover
RECRUITINGHanover, Lower Saxony, 30625, Germany
-
Monash Health
RECRUITINGClayton, Victoria, 3168, Australia
-
Nagoya City University Hospital
RECRUITINGNagoya, Aichi-ken, 467-8602, Japan
-
National Cancer Center Hospital East
RECRUITINGKashiwa, Chiba, 277-8577, Japan
-
National Hospital Organization Okayama Medical Center
RECRUITINGOkayama, 701-1192, Japan
-
National Taiwan University Cancer Center (NTUCC)
RECRUITINGTaipei City, Taipei, 106, Taiwan
-
National Taiwan University Hospital
RECRUITINGTaipei, 10002, Taiwan
-
National University Hospital
RECRUITINGSingapore, Central Singapore, 119074, Singapore
-
Odense Universitetshospital
RECRUITINGOdense, Region Syddanmark, 5000, Denmark
-
Ordensklinikum Linz GmbH Elisabethinen
RECRUITINGLinz, Upper Austria, 4020, Austria
-
Osaka Red Cross Hospital
RECRUITINGOsaka, 543-8555, Japan
-
Oulun yliopistollinen sairaala
RECRUITINGOulu, 90220, Finland
-
P.O. "S. Maria della Misericordia" Azienda Sanitaria Universitaria Friuli Centrale
RECRUITINGUdine, 33100, Italy
-
Peter MacCallum Cancer Centre
RECRUITINGMelbourne, Victoria, 3000, Australia
-
Princess Alexandra Hospital
RECRUITINGBrisbane, Queensland, 4102, Australia
-
QEII Health Sciences Centre - Victoria General Site
RECRUITINGHalifax, Nova Scotia, B3H 2Y9, Canada
-
Radboudumc
RECRUITINGNijmegen, Gelderland, 6525 GA, Netherlands
-
Rigshospitalet
RECRUITINGCopenhagen, Capital Region, 2100, Denmark
-
Roskilde Sygehus
RECRUITINGRoskilde, Region Sjælland, 4000, Denmark
-
Royal Adelaide Hospital
RECRUITINGAdelaide, South Australia, 5000, Australia
-
Royal Prince Alfred Hospital
RECRUITINGCamperdown, New South Wales, 2050, Australia
-
Sahlgrenska Universitetssjukhuset
RECRUITINGGothenburg, Västra Götalands Län [se-14], 413 45, Sweden
-
Samsung Medical Center
RECRUITINGSeoul, Seoul-teukbyeolsi [Seoul], 06351, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, Seoul-teukbyeolsi [Seoul], 03080, South Korea
-
Sheba Medical Center
RECRUITINGRamat Gan, Central District, 5262100, Israel
-
Sheffield Teaching Hospitals NHS Foundation Trust
RECRUITINGSheffield, S10 2JF, United Kingdom
-
Skånes Universitetssjukhus Lund
RECRUITINGLund, 222 42, Sweden
-
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
RECRUITINGSão Paulo, 05652-900, Brazil
-
Sourasky Medical Center
RECRUITINGTel Aviv, Tell Abīb, 6423906, Israel
-
Spitalul Universitar de Urgență București
RECRUITINGBucharest, 050098, Romania
-
Sykehusapoteket Ull
RECRUITINGOslo, 0450, Norway
-
TUM Klinikum
RECRUITINGMunich, Bavaria, 81675, Germany
-
Taipei Veterans General Hospital
RECRUITINGTaipei, 11217, Taiwan
-
The Alfred Hospital
RECRUITINGMelbourne, Victoria, 3004, Australia
-
The Catholic Univ. of Korea Seoul St. Mary's Hospital
RECRUITINGSeoul, Seoul-teukbyeolsi [Seoul], 06591, South Korea
-
The Christie NHS Foundation Trust
RECRUITINGManchester, M20 4BX, United Kingdom
-
Turku University Hospital
RECRUITINGTurku, 20251, Finland
-
UCLA Hematology/Oncology - Santa Monica
RECRUITINGLos Angeles, California, 90404, United States
-
UZ Gent
RECRUITINGGhent, Oost-Vlaanderen, 9000, Belgium
-
Universitaetsklinikum Hamburg-Eppendorf
RECRUITINGHamburg, 20246, Germany
-
Universitaetsklinikum Heidelberg
RECRUITINGHeidelberg, D-69120, Germany
-
Universitaetsklinikum Magdeburg
RECRUITINGMagdeburg, Saxony-Anhalt, 39120, Germany
-
Universitaetsklinikum Schleswig-Holstein Campus Kiel
RECRUITINGKiel, Schleswig-Holstein, 24105, Germany
-
Universitaetsklinikum Wuerzburg
RECRUITINGWürzburg, 97080, Germany
-
Universitair Medisch Centrum Utrecht
RECRUITINGUtrecht, 3584 CX, Netherlands
-
University College London Hospital
RECRUITINGLondon, London, City of, NW1 2PG, United Kingdom
-
University Hospital of Patras
RECRUITINGPátrai, Achaḯa, 26504, Greece
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35205, United States
-
University of California, Irvine (UCI) Health - UC Irvine Medical Center
RECRUITINGOrange, California, 92868, United States
-
University of Miami Hospital and Clinics, Sylvester Cancer Center
RECRUITINGMiami, Florida, 33136, United States
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Universitätsklinikum Leipzig
RECRUITINGLeipzig, Saxony, 04103, Germany
-
Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godinne
RECRUITINGYvoir, Namur, 5530, Belgium
-
Uniwersyteckie Centrum Kliniczne
RECRUITINGGdansk, Pomeranian Voivodeship, 80-214, Poland
-
Vancouver General Hospital
RECRUITINGVancouver, British Columbia, V5Z 1M9, Canada
-
Vseobecna fakultni nemocnice v Praze
RECRUITINGPrague, 12808, Czechia
-
Weill Cornell Medical College
RECRUITINGNew York, New York, 10065, United States
-
Winship Cancer Institute, Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
-
Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Lodzi
RECRUITINGLodz, Łódź Voivodeship, 93-513, Poland
-
Yamagata University Hospital
RECRUITINGYamagata, 990-9585, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists test CAR-T cells made inside the body to fight Hard-to-Treat myeloma
- New antibody drug aims to outsmart Treatment-Resistant myeloma
- New hope for Tough-to-Treat blood cancer: phase 3 trial launched
- New Three-Drug cocktail aims to tackle Hard-to-Treat multiple myeloma
- Double-Barreled CAR-T cells take aim at Hard-to-Treat myeloma
- Double-Barreled CAR-T attack on Hard-to-Treat myeloma